IDEAS home Printed from https://ideas.repec.org/a/sae/jjlobr/v12y2023i1p73-84.html
   My bibliography  Save this article

Decoding a Doctor’s Prescription: A Study

Author

Listed:
  • Cedric Thomas Silveira

Abstract

Doctors today have very little time to listen to a medical representative. They have become patient-centric and feel that listening to a medical representative is a waste of their time. Wishing to learn what could make a doctor prescribe a drug when visited by the medical representative, I drew up a questionnaire consisting of product-centric variables and non-product-based variables. The questionnaire had six variables, which had to be ranked from 1 to 6, with 1 being the most important and 6 being the least important. The variables were easy availability, economical drugs, company name, sponsorships, medical representative’s dedication, and samples among the non-product-based variables and safety, efficacy, tried and tested, less drug interactions, good reviews of the drug, and less adverse effects among the product-based factors. A total of 100 doctors were interviewed. A personal interview was conducted wherein the questionnaire was direct and structured. The results were such that in Thurstone Case V Scaling, economical drugs were considered as the most effective way to get doctors to prescribe, followed by easy availability, company name, medical rep dedication, samples, and sponsorships among the non-product-centric factors, whereas in the product-centric factors, it included efficacy, followed by time tested, less adverse effects, safety, less drug interactions, and good drug reviews. In Karl Pearson’s coefficient of correlation, it was found that a high, positive correlation existed between economical drugs and efficacious drugs and a medium, positive correlation existed between economical drugs and safe drugs. Similarly, a medium–high correlation existed between company name and time-tested drugs.

Suggested Citation

  • Cedric Thomas Silveira, 2023. "Decoding a Doctor’s Prescription: A Study," Jindal Journal of Business Research, , vol. 12(1), pages 73-84, June.
    • Handle: RePEc:sae:jjlobr:v:12:y:2023:i:1:p:73-84
    DOI: 10.1177/22786821231161247
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/22786821231161247
    Download Restriction: no
    File URL: https://libkey.io/10.1177/22786821231161247?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Bhuvanesh Pareek & Qiang Liu & Pulak Ghosh, 2019. "Ask your doctor whether this product is right for you: a Bayesian joint model for patient drug requests and physician prescriptions," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 182(1), pages 197-223, January.
    2. Farzana Elahi & Shamsad Ahmed & Mahbubul Haque & Nazreen Chowdhury, 2016. "An Empirical Investigation into Physician Preferences in Drug Prescription: An Integrated Methodology of AHP and QFD," International Journal of Marketing Studies, Canadian Center of Science and Education, vol. 8(5), pages 81-89, October.
    3. Ramkumar Janakiraman & Shantanu Dutta & Catarina Sismeiro & Philip Stern, 2008. "Physicians' Persistence and Its Implications for Their Response to Promotion of Prescription Drugs," Management Science, INFORMS, vol. 54(6), pages 1080-1093, June.
    4. G Michael Allan & Joel Lexchin & Natasha Wiebe, 2007. "Physician Awareness of Drug Cost: A Systematic Review," PLOS Medicine, Public Library of Science, vol. 4(9), pages 1-11, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Raf Van Gestel & Tobias Müller & Johan Bosmans, 2018. "Learning from failure in healthcare: Dynamic panel evidence of a physician shock effect," Health Economics, John Wiley & Sons, Ltd., vol. 27(9), pages 1340-1353, September.
    2. Katharina E. Blankart & Frank R. Lichtenberg, 2022. "The Effects of Off-label Drug Use on Disability and Medical Expenditure," NBER Working Papers 30440, National Bureau of Economic Research, Inc.
    3. Xiaojing Dong & Pradeep Chintagunta & Puneet Manchanda, 2011. "A new multivariate count data model to study multi-category physician prescription behavior," Quantitative Marketing and Economics (QME), Springer, vol. 9(3), pages 301-337, September.
    4. Stefan Stremersch & Vardit Landsman & Sriram Venkataraman, 2013. "The Relationship Between DTCA, Drug Requests, and Prescriptions: Uncovering Variation in Specialty and Space," Marketing Science, INFORMS, vol. 32(1), pages 89-110, June.
    5. G Michael Allan & Christina Korownyk & Kate LaSalle & Ben Vandermeer & Victoria Ma & Douglas Klein & Donna Manca, 2010. "Do Randomized Controlled Trials Discuss Healthcare Costs?," PLOS ONE, Public Library of Science, vol. 5(8), pages 1-5, August.
    6. Gauri Billa & Karan Thakkar & Sarita Jaiswar & Dinesh Dhodi, 2014. "A Cross-Sectional Study to Evaluate the Awareness and Attitudes of Physicians Towards Reducing the Cost of Prescription Drugs, Mumbai," Applied Health Economics and Health Policy, Springer, vol. 12(2), pages 125-137, April.
    7. Barkowski, Scott, 2021. "Physician Response to Prices of Other Physicians: Evidence from a Field Experiment," MPRA Paper 108966, University Library of Munich, Germany.
    8. Stefanie Heinzle, 2012. "Disclosure of Energy Operating Cost Information: A Silver Bullet for Overcoming the Energy-Efficiency Gap?," Journal of Consumer Policy, Springer, vol. 35(1), pages 43-64, March.
    9. Lexchin, Joel, 2009. "Pricing of multiple dosage prescription medications: An analysis of the Ontario Drug Benefit Formulary," Health Policy, Elsevier, vol. 91(2), pages 142-147, July.
    10. Ida Iren Eriksen & Hans Olav Melberg & Berit Bringedal, 2013. "Norwegian Physicians’ Knowledge of the Prices of Pharmaceuticals: A Survey," PLOS ONE, Public Library of Science, vol. 8(9), pages 1-1, September.
    11. Qiang Liu & Hongju Liu & Manohar Kalwani, 2020. "“See your doctor”: the impact of direct-to-consumer advertising on patients with different affliction levels," Marketing Letters, Springer, vol. 31(1), pages 37-48, March.
    12. Carey, Colleen & Lieber, Ethan M.J. & Miller, Sarah, 2021. "Drug firms’ payments and physicians’ prescribing behavior in Medicare Part D," Journal of Public Economics, Elsevier, vol. 197(C).
    13. Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
    14. Appelt, Silvia, 2010. "Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry," Discussion Papers in Economics 11476, University of Munich, Department of Economics.
    15. Hongju Liu & Qiang Liu & Pradeep K. Chintagunta, 2017. "Promotion Spillovers: Drug Detailing in Combination Therapy," Marketing Science, INFORMS, vol. 36(3), pages 382-401, May.
    16. Rizwan Raheem Ahmed & Dalia Streimikiene & Josef Abrhám & Justas Streimikis & Jolita Vveinhardt, 2020. "Social and Behavioral Theories and Physician’s Prescription Behavior," Sustainability, MDPI, vol. 12(8), pages 1-25, April.
    17. Magno, Cielo & Guzman, Ricardo Rafael S., 2019. "Drug price sensitivity among physicians in a developing healthcare system: Evidence from the Philippine market for statins and beta blockers," Economic Analysis and Policy, Elsevier, vol. 62(C), pages 268-279.
    18. Sismeiro, Catarina & Mizik, Natalie & Bucklin, Randolph E., 2012. "Modeling coexisting business scenarios with time-series panel data: A dynamics-based segmentation approach," International Journal of Research in Marketing, Elsevier, vol. 29(2), pages 134-147.
    19. Timothée Lehut & Céline Lambert & Romain Mortier & Emmanuel Futier & Russell Chabanne & Ulrich Bauer & Philippe Verdier & Ramin Ravan & Philippe Ocquidant & Charline Mourgues & Alexandre Lautrette, 2024. "Cost awareness among intensivists in their daily clinical practice: a prospective multicentre study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(9), pages 1529-1537, December.
    20. Raf Van Gestel & Tobias Mueller & Johan Bosmans, 2018. "Learning from failure in healthcare: Dynamic panel evidence of a physician shock effect," Diskussionsschriften dp1809, Universitaet Bern, Departement Volkswirtschaft.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:jjlobr:v:12:y:2023:i:1:p:73-84. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.